Martínez Bailén, M., Carmona Asenjo, A. T., Cardona, F., Matassini, C., Goti, A., Kubo, M., . . . Moreno Vargas, A. J. (2020). Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.
Citación estilo ChicagoMartínez Bailén, Macarena, Ana Teresa Carmona Asenjo, Francesca Cardona, Camilla Matassini, Andrea Goti, Moemi Kubo, Atsushi Kato, Inmaculada Robina Ramírez, y Antonio José Moreno Vargas. Synthesis of Multimeric Pyrrolidine Iminosugar Inhibitors of Human β-glucocerebrosidase and α-galactosidase A: First Example of a Multivalent Enzyme Activity Enhancer for Fabry Disease. 2020.
Cita MLAMartínez Bailén, Macarena, et al. Synthesis of Multimeric Pyrrolidine Iminosugar Inhibitors of Human β-glucocerebrosidase and α-galactosidase A: First Example of a Multivalent Enzyme Activity Enhancer for Fabry Disease. 2020.